Delivery Order SPE2DB22D3501-SPE2DB25FXM87
- Not listed
- The Defense Logistics Agency awarded a $33,921.62 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5, 5-unit packs) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,655.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5, 5-pack configuration) on August 25, 2025, with completion scheduled for August 26, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a $3,840.79 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring system pods (Generation 5) with a 5-second sensor. This competitively awarded, firm fixed-price contract was executed on September 24, 2025, with an ultimate completion date of September 25, 2025, and represents fulfillment under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,983.80 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a 5-sensor configuration. The contract was competitively awarded without set-aside designation and carries a completion date of June 10, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $17,251.15 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The OmniPod system represents a critical medical device for diabetes management,...
- The Defense Logistics Agency awarded a $73,667 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a completion date of September 15, 2025. This non-set-aside competitive award was issued on September 12, 2025, for delivery to the Conshohocken, Pennsylvania location. The products represent specialized diabetes management medical devices that support military and veteran healthcare systems through the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.48 to AmerisourceBergen Drug Corp on September 16, 2025, for OmniPod 5 Dexcom G7 Gen 5 pods (5-pack units). This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical and medical supply procurement under AmerisourceBergen's larger contract vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $14,685.60 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for OmniPod 5 Dexcom G7 continuous glucose monitoring pods (Generation 5), with a completion date of September 12, 2025. The award was competitively procured with no set-aside designation and reflects firm fixed pricing terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The Defense Logistics Agency awarded a $1,784.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7 Gen 5 insulin infusion pods. The contract, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a competitive award with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $1,372.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXM87Delivery Order
The Defense Logistics Agency awarded a $14,233.56 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OmniPod 5 continuous glucose monitoring pods (Generation 5) for 5-day use. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award draws from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to supply a wide range of pharmaceutical products and medical devices across multiple therapeutic domains. This delivery order for continuous glucose monitoring pods supports the military healthcare supply chain and aligns with the company's established role as a key provider of specialized medical supplies and diabetes management technologies to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 9/23/25 |